Latest Strategic Planning News

Page 7 of 27
Elixir Energy secures a $16.6 million capital raise led by Omega Oil and Gas, propelling Phase-2 of its strategic plan to unlock reserves in Queensland’s Taroom Trough.
Maxwell Dee
Maxwell Dee
25 Nov 2025
Elixir Energy secures $16.6 million in a capital raise led by Omega Oil and Gas, unlocking Phase-2 of its strategic plan to define reserves in Queensland’s Taroom Trough. This funding accelerates appraisal drilling and production testing, positioning Elixir for a pivotal year ahead.
Maxwell Dee
Maxwell Dee
25 Nov 2025
Pure Foods Tasmania has acquired premium ice cream brand Elato, integrating it with its Cashew Creamery to form a new Ice Cream Division led by Elato’s founder. This move broadens PFT’s product range and leverages existing manufacturing capabilities.
Eva Park
Eva Park
25 Nov 2025
Pro Medicus Ltd has delivered a record-breaking FY2025 with revenue soaring nearly 32% and net profit up 39%, driven by landmark contracts and a robust growth pipeline.
Ada Torres
Ada Torres
24 Nov 2025
Santana Minerals has secured formal acceptance from New Zealand's Environmental Protection Authority for its Fast-track Approvals application, moving the Bendigo-Ophir Gold Project closer to construction.
Maxwell Dee
Maxwell Dee
24 Nov 2025
Atomic Eagle Ltd, formerly known as Tombador Iron Limited, will have its trading suspension lifted and be reinstated to quotation on the ASX starting 24 November 2025 after meeting key compliance requirements.
Maxwell Dee
Maxwell Dee
21 Nov 2025
Emu NL announces the departure of CEO Adrian Griffin and the appointment of Non-Executive Director Peter Swiridiuk as interim CEO, signaling a leadership transition at the mining explorer.
Maxwell Dee
Maxwell Dee
20 Nov 2025
Saturn Metals has mobilised additional drilling rigs at its Apollo Hill Gold Project following promising assay results that extend the high-grade Iris Trend by 900 metres and highlight potential to grow the 2.24 million ounce resource.
Maxwell Dee
Maxwell Dee
20 Nov 2025
Prescient Therapeutics has achieved a key regulatory milestone with the European Medicines Agency granting Orphan Drug Designation for its PTX-100 therapy targeting Cutaneous T-cell Lymphomas, enhancing its commercial and clinical prospects in Europe.
Ada Torres
Ada Torres
19 Nov 2025
Webjet Group reported steady first-half results despite a challenging domestic leisure market, declaring its first fully franked interim dividend and accelerating its FY30 strategic initiatives.
Victor Sage
Victor Sage
19 Nov 2025
Webjet Group reports steady first-half results with a 16% rise in underlying profit and announces its inaugural fully franked interim dividend, signalling confidence despite a challenging travel market.
Victor Sage
Victor Sage
19 Nov 2025
Webjet Group reported a slight revenue dip and a mixed earnings performance for the half-year ended September 2025, while unveiling its inaugural dividend and receiving a non-binding takeover offer from Helloworld Travel.
Victor Sage
Victor Sage
19 Nov 2025